Response by Park and Kang to Letter Regarding Article, "Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial"

Circulation. 2025 Jan 21;151(3):e28. doi: 10.1161/CIRCULATIONAHA.124.072232. Epub 2025 Jan 21.

Authors

Sung-Ji Park¹, Duk-Hyun Kang²

Affiliations

¹ Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea (S.-J.P.).
² Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea (D.-H.K.).

PMID: 39836758
DOI: 10.1161/CIRCULATIONAHA.124.072232

No abstract available

Publication types

Letter